ClinicalTrials.govpublic full text
iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma
melanoma (skin cancer), advanced melanoma, metastatic melanoma, skin cancer, melanoma, cancer vaccine, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 982767
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.